Standard model species are commonly used in toxicity tests due to their biological and technical advantages but studying native species increases the specificity and relevance of results generated for the potential risk assessment to an ecosystem. Accounting for intraspecies variability and other factors, such as chemical and physical characterization of test medium, is necessary to develop a reproducible bioassay for toxicity testing with native species. In this study, larval stage I American lobster (Homarus americanus), a commercially important and native species of Atlantic Canada, was used as the test species. Toxicity tests were first conducted by exposing lobster larvae to a reference toxicant of copper sulphate (CuSO4) and then to physically and chemically (using Corexit 9500A) dispersed oil (WAF and CEWAF, respectively). The effect on larval survival was estimated by calculating the 24-h median effect concentration (24-h EC50), and there was no difference between WAF or CEWAF exposure when the results are reported on a total petroleum hydrocarbon (TPH) basis. The 24-h EC50s ranged from 2.54 to 9.73 mg TPH/L when all trials (n = 19) are considered together. The HC5 (hazardous concentration for 5 per cent of the population) value was 2.52 mg TPH/L and similar to the EC50 value when all trials were pooled. To evaluate the reproducibility of the lobster toxicity tests, inter-trial variability was determined, and the resultant coefficients of variation (%CV) were compared to those reported for two standard test species, mysid shrimp (Americamysis bahia) and inland silverside (Menidia beryillina). This comparison showed that the %CV for the lobster toxicity tests were lower than those for the standard species tests indicating that the described larval lobster toxicity bioassay produces reliable and repeatable results.
Standard model species are commonly used in toxicity tests due to their biological and technical advantages but studying native species increases the specificity and relevance of results generated for the potential risk assessment to an ecosystem. Accounting for intraspecies variability and other factors, such as chemical and physical characterization of test medium, is necessary to develop a reproducible bioassay for toxicity testing with native species. In this study, larval stage I American lobster (Homarus americanus) was selected as the test species, which is native to Atlantic Canada. Toxicity tests were first conducted exposing lobster larvae to a reference toxicant of copper sulfate (CuSO4) and then to physically and chemically dispersed oil. The effect on larval survival was estimated by calculating the median effect concentration (EC50) as 2.54-9.73 mg TPH/L when all trials are considered together. The HC5 or PNEC value was 2.52 mg TPH/L and therefore a narrow difference from the EC50 value. The inter-trial variability (coefficient of variability = 17%) was lower than the US Environmental Protection Agency standard test species of mysid shrimp (Americamysis bahia) and inland silversides (Menidia bervillina). Our results indicate that the described larval lobster bioassay is reliable to produce repeatable results for this commercially important and native species of Atlantic Canada.
Climate change, the opening of the northwest passage, the production and transportation of oil reserves in addition to the large size and number of ocean-going vessels, are putting all Canada's oceans at an elevated risk for an oil spill. Responses to marine oil spills include physical (skimming and recovery), chemical (dispersants, herders) and biological processes (biodegradation). Natural attenuation, a weathering process that includes physical, chemical and biological action on spilled oil, is a potential remediation strategy that needs to be explored and exploited. In the Canadian context, we are using genomics approaches to better understand the natural populations of oil degrading microorganisms in our oceans, their diversity, spatial and temporal dynamics, and locations that may be more vulnerable to oil spills.
The purpose of this study was to perform an evaluation of the effectiveness of an in situ microcosm experimental system to study indigenous microbial communities that have oil degrading potential and to determine whether this experimental system could have an impact on acute toxicity to various marine organisms. In situ microcosms are slitted columns that contain support matrices such as clay beads or river rocks, with or without an oil coating. Columns can be incubated in different locations, at different depths and different time periods, during which microbial biofilm develops on the support materials. By using oil coated and uncoated matrices, comparative microbial community data that demonstrates the response of the microbial community to the presence of oil can be obtained. Long-term incubations (1 year) conducted at CFS-Alert showed that known oil-degrading bacteria (Colwellia, Oleibacter, Thalassolituus, Cycloclasticus, Oceanobacter and Alcanivorax) became dominant only on the oil coated matrices, confirming their presence in the local seawater.
Acute toxicity tests were performed in aquaria on a variety of test organisms to evaluate the possible effects of oil components leaching into the water from the in situ microcosms. Limited and transient toxicity to only two tested organisms (green sea urchin fertilization and green algal growth). Considering the analyses were conducted in a closed circulation system, it is highly likely that in an open ocean environment, toxicity would be negligible. Data from these studies will be valuable to support guidelines for the exploitation of natural attenuation as an alternative response measure (ARM) to address oil spills in Canadian waters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.